Blair William & CO Allakos Inc. Transaction History

Blair William & CO

$32 Billion
Q2 2024

A detailed history of Blair William & CO transactions in Allakos Inc. stock. As of the latest transaction made, Blair William & CO holds 64,817 shares of ALLK stock, worth $91,391. This represents 0.0% of its overall portfolio holdings.

Number of Shares

64,817

Previous 85,817 24.47%

Holding current value

$91,391

Previous $108,000 40.74%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	SELL	$1.0 - $1.45 $21,000 - $30,450	-21,000 Reduced 24.47%	64,817 $64,000
Q1 2024 May 09, 2024	SELL	$1.02 - $3.23 $23,358 - $73,967	-22,900 Reduced 21.06%	85,817 $108,000
Q4 2023 Feb 12, 2024	BUY	$1.72 - $3.18 $37,840 - $69,960	22,000 Added 25.37%	108,717 $296,000
Q3 2023 Nov 09, 2023	SELL	$2.13 - $5.55 $7,455 - $19,425	-3,500 Reduced 3.88%	86,717 $196,000
Q2 2023 Aug 11, 2023	BUY	$3.6 - $5.25 $73,800 - $107,625	20,500 Added 29.4%	90,217 $393,000
Q1 2023 May 12, 2023	BUY	$4.3 - $8.27 $38,700 - $74,430	9,000 Added 14.82%	69,717 $310,000
Q4 2022 Feb 10, 2023	BUY	$5.66 - $8.42 $27,734 - $41,258	4,900 Added 8.78%	60,717 $511,000
Q3 2022 Nov 09, 2022	BUY	$3.02 - $6.12 $135,084 - $273,747	44,730 Added 403.45%	55,817 $342,000
Q2 2022 Aug 10, 2022	BUY	$2.6 - $6.14 $28,826 - $68,074	11,087 New	11,087 $35,000
Q4 2021 Feb 14, 2022	SELL	$8.55 - $111.89 $105,165 - $1.38 Million	-12,300 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$76.53 - $110.43 $243,748 - $351,719	3,185 Added 34.94%	12,300 $1.3 Million
Q2 2021 Aug 12, 2021	SELL	$85.37 - $114.1 $29,367 - $39,250	-344 Reduced 3.64%	9,115 $778,000
Q1 2021 May 13, 2021	BUY	$109.73 - $153.66 $9,327 - $13,061	85 Added 0.91%	9,459 $1.09 Million
Q4 2020 Feb 09, 2021	BUY	$79.58 - $152.45 $745,982 - $1.43 Million	9,374 New	9,374 $1.31 Million
Q1 2020 May 11, 2020	SELL	$44.49 - $93.39 $562,576 - $1.18 Million	-12,645 Closed	0 $0
Q4 2019 Feb 13, 2020	BUY	$66.49 - $137.73 $840,766 - $1.74 Million	12,645 New	12,645 $1.21 Million
Q4 2018 Feb 14, 2019	SELL	$31.59 - $62.65 $243,243 - $482,405	-7,700 Closed	0 $0
Q3 2018 Nov 13, 2018	BUY	$31.25 - $47.64 $240,625 - $366,828	7,700 New	7,700 $346,000

Others Institutions Holding ALLK

# of Institutions

Shares Held

70.7M

Call Options Held

43.8K

Put Options Held

1.4K

View Full List

About Allakos Inc.

Ticker ALLK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 84,726,096
Market Cap $119M
Description
Allakos Inc., a clinical stage biopharmaceutical company, develops therapeutics that target immunomodulatory receptors present on immune effector cells in allergy, inflammatory, and proliferative diseases. The company's lead monoclonal antibody is lirentelimab (AK002), which is in a Phase III study for the treatment of eosinophilic gastritis and...

More about ALLK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Blair William & CO, based on Form 13F filings with the SEC.

News

Stay updated on Blair William & CO with notifications on news.

Account